IGFBP3 and central nervous system cancer: Analysis of the survival effect of IGFBP-3 expression in all cancers identified its highly significant effect on survival in glioma (FDR = 1.51∙10−32 (Hazard Ratio, HR = 4.39)) (Figure 5A and Figure 6A).